RE:RE:Do The Right ThingA simple update addressing the government funding and an explanation why the PP is still needed if the funding goes through. It would clear the optics of an underpriced PP right before preclinical trial results are to be released that allows insiders and brokers to fill their pockets on cheap shares , when the press release 3 weeks prior PP said no funding required? The company needs to issue a statement.